← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Actinobac Biomed, Inc.
Kendall Park, NJ
$2,250,118
Total funding
2
Grants
Funding over time
peak $905K · FY2012–16$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,250,118 · 2
By mechanism
R42$1,939,262 · 1
R41$310,856 · 1
Investigators at Actinobac Biomed, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Targeting B-cell lymphoma with Leukothera-phase II$905,040
R42 · FY2014 · CA
Targeting B-cell lymphoma with Leukothera-phase II$894,222
R42 · FY2015 · CA
Targeting B-cell lymphoma with Leukothera$202,601
R41 · FY2012 · CA
Targeting B-cell lymphoma with Leukothera-phase II$140,000
R42 · FY2016 · CA
Targeting B-cell lymphoma with Leukothera$108,255
R41 · FY2013 · CA